Research outputs
2026
Pharmacokinetics of Dolutegravir, nucleoside analogues, and intracellular metabolites using plasma separation cards: A comparative analysis with traditional sampling methods in healthy volunteers
Thompson, B., Else, L. J., Dickinson, L., Edick, S., Zyhowski, A., Ho, K., . . . Brand, R. M. (2026). Pharmacokinetics of Dolutegravir, nucleoside analogues, and intracellular metabolites using plasma separation cards: A comparative analysis with traditional sampling methods in healthy volunteers. PLOS ONE, 21(1). doi:10.1371/journal.pone.0341252
2025
Drug interactions between probe drugs dolutegravir (DTG), midazolam (MDZ) and digoxin (DIG) with escalating doses of rifampicin (RIF): DORIS study
Thompson, B. (2025). Drug interactions between probe drugs dolutegravir (DTG), midazolam (MDZ) and digoxin (DIG) with escalating doses of rifampicin (RIF): DORIS study. In International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2025. doi:10.1002/bcp.70214
Pharmacokinetics of nitazoxanide in plasma separation cards from patients with SARS-CoV-2: AGILE CST-3a/b
Thompson, B. (2025). Pharmacokinetics of nitazoxanide in plasma separation cards from patients with SARS-CoV-2: AGILE CST-3a/b. In International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2025. doi:10.1002/bcp.70232
Drug interactions between probe drugs dolutegravir (DTG), midazolam (MDZ) and digoxin (DIG) with escalating doses of rifampicin (RIF): DORIS study
Dickinson, L., Singh, Y., Semakula, J., Chodacki, P., Kassim, S., Namuddu, D., . . . Khoo, S. (2025). Drug interactions between probe drugs dolutegravir (DTG), midazolam (MDZ) and digoxin (DIG) with escalating doses of rifampicin (RIF): DORIS study. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 91, 12. doi:10.1002/bcp.70214
Pharmacokinetics of nitazoxanide in plasma separation cards from patients with SARS-CoV-2: AGILE CST-3a/b
Thompson, B., Else, L., Amara, A., Reynolds, H., Lyon, R., Chiong, J., . . . Khoo, S. (2025). Pharmacokinetics of nitazoxanide in plasma separation cards from patients with SARS-CoV-2: AGILE CST-3a/b. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 91, 21-22. doi:10.1002/bcp.70232
2024
Evaluation of pharmacokinetics of Tenofovir Alafenamide (TAF) and Tenofovir Disoproxil (TDF) in pregnant and postpartum women in South Africa: PrEP-PP PK study
Davey, D. J., Dadan, S., Bheemraj, K., Waitt, C., Khoo, S., Myer, L., . . . Orrell, C. (2024). Evaluation of pharmacokinetics of Tenofovir Alafenamide (TAF) and Tenofovir Disoproxil (TDF) in pregnant and postpartum women in South Africa: PrEP-PP PK study. ANTIVIRAL RESEARCH, 231. doi:10.1016/j.antiviral.2024.106014
Preclinical pharmacokinetics of novel long-acting tenofovir alafenamide/bictegravir solid injectable in rats
Arshad, U., Barlow, E., Cox, H., Sharp, J., Pertinez, H., Herriott, J., . . . Owen, A. (2024). Preclinical pharmacokinetics of novel long-acting tenofovir alafenamide/bictegravir solid injectable in rats. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 90, 3. Retrieved from https://www.webofscience.com/
Tenofovir, emtricitabine, lamivudine and dolutegravir concentrations in plasma and urine following drug intake cessation in a randomized controlled directly observed pharmacokinetic trial to aid point-of-care testing.
Else, L. J., Dickinson, L., Edick, S., Zyhowski, A., Ho, K., Meyn, L., . . . Brand, R. M. (2024). Tenofovir, emtricitabine, lamivudine and dolutegravir concentrations in plasma and urine following drug intake cessation in a randomized controlled directly observed pharmacokinetic trial to aid point-of-care testing.. The Journal of antimicrobial chemotherapy, 79(7), 1597-1605. doi:10.1093/jac/dkae147
Development and application of novel dried blood spot methods for the quantification of antiretroviral drugs and their metabolites
Thompson, B. (2024, April 17). Development and application of novel dried blood spot methods for the quantification of antiretroviral drugs and their metabolites.
2023
Application of novel plasma separation filter cards for quantification of nucleoside/nucleotide reverse transcriptase inhibitor di/triphosphates in dried blood spot using LC-MS
Thompson, B., Dilly-Penchala, S., Amara, A., Reynolds, H., Khoo, S., & Else, L. (2023). Application of novel plasma separation filter cards for quantification of nucleoside/nucleotide reverse transcriptase inhibitor di/triphosphates in dried blood spot using LC-MS. BIOANALYSIS, 15(13), 739-756. doi:10.4155/bio-2023-0057